Biotech companies are seeing significant pre-market activity this Wednesday, hinting at possible breakout opportunities.
By evaluating sentiment and momentum before the bell, premarket analysis becomes a foundational step in any trader's routine.
In the Green - Premarket Gainers
On Wednesday, the following stocks are trading significantly higher in the premarket session.
1. Rigel Pharmaceuticals Inc. (RIGL) - up 22% at $34.502. CareDx Inc. (CDNA) - up 12% at $16.303. Veracyte Inc. (VCYT) - up 11% at $40.004. Immunitybio Inc. (IBRX) - up 11% at $2.315. EUDA Health Holdings Ltd. (EUDA) -up 7% at $2.586. Pacific Biosciences of California Inc. (PACB) -up 5% at $2.107. Fibrobiologics Inc. (FBLG) - up 4% at $0.348. Ernexa Therapeutics Inc. (ERNA) - up 3% at $1.739. Edgewise Therapeutics Inc. (EWTX) - up 1% at $17.5010. Lexaria Bioscience Corp. (LEXX) - up 1% at $1.12
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.